Scholarly Index
Anthony M. Joshua
The Kinghorn Cancer Centre; 29,282 total citations; 525 total publications; best world rank #30
The Kinghorn Cancer Centre
29,282Total citations
525Total publications
69H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Radiopharmaceutical Chemistry and Applications | Lifetime | 160 | AU 8 | 98.83 |
| Cancer Immunotherapy and Biomarkers | Lifetime | 416 | AU 18 | 99.04 |
| Prostate Cancer Treatment and Research | Lifetime | 273 | AU 6 | 99.14 |
| Cancer, Lipids, and Metabolism | Lifetime | 538 | AU 11 | 98.02 |
| CAR-T cell therapy research | Lifetime | 794 | AU 31 | 97.91 |
| Ocular Oncology and Treatments | Lifetime | 169 | AU 3 | 96.84 |
| PARP inhibition in cancer therapy | Lifetime | 578 | AU 13 | 93.90 |
| Melanoma and MAPK Pathways | Lifetime | 705 | AU 39 | 93.55 |
| Prostate Cancer Treatment and Research | 2021-2025 | 41 | AU 6 | 99.49 |
| Cancer, Lipids, and Metabolism | 2021-2025 | 53 | AU 6 | 98.43 |
| Ocular Oncology and Treatments | 2021-2025 | 30 | AU 1 | 96.99 |
| Radiopharmaceutical Chemistry and Applications | 2021-2025 | 105 | AU 12 | 97.26 |
| Cancer Immunotherapy and Biomarkers | 2021-2025 | 714 | AU 19 | 97.27 |
| Immunotherapy and Immune Responses | 2021-2025 | 703 | AU 34 | 92.60 |
| PARP inhibition in cancer therapy | 2021-2025 | 200 | AU 7 | 93.38 |
| Melanoma and MAPK Pathways | 2021-2025 | 486 | AU 34 | 79.38 |